COMP <GO>
LITS vs NNVC // 10Y YIELD & FRED MACRO BETA
Lite Strategy Inc. (NASDAQ) VS. NanoViricides Inc. (NYSE) • 15-METRIC TALLY: LITS 1
— NNVC 3
■ METRIC PARITY
LAST: $1.17 (-4.88%) • MKT CAP: $35.6M
macro-sensitivity
—
LAST: $1.43 (-1.38%) • MKT CAP: $36.5M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LITS VS. NNVC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LITS | NNVC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -18.90% | -35.00% | +16.10 | LITS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -23.37% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 11.68 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 2/9 | -1.00 | NNVC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.0 | 47.0 | -3.10 | NNVC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $35.6M | $36.5M | -$944.9K | NNVC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LITS REV | NNVC REV | LITS GROSS % | NNVC GROSS % | LITS FCF | NNVC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$20.8M | -$8.5M |
| FY 2024 | $65.3M | $0 | — | — | -$50.5M | -$6.5M |
| FY 2023 | $48.8M | $0 | — | — | -$52.5M | -$5.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LITS // BETA —
NNVC // BETA —